Commercialization models for Virtual Care in Cardiometabolic Diseases

 Cardiometabolic diseases such as heart failure, stroke, type 2 diabetes, hypertension, amongst others, are leading causes of death globally. Since symptoms and signs can be easily measured by technology, cardiometabolic diseases is one of the areas that has benefited the most from Remote Patient Monitoring (RPM) programs so far, showing promising clinical and economic outcomes on multiple occasions. But beyond evidence and outcomes, getting paid for these solutions is one of the biggest challenges. Finding the right commercialization model is not easy work for digital health companies operating in this space. Join us in this informal conversation where we will discuss: